Patent Yard Sign in
Expired Canadian patentCanada

Methods of inducing immune tolerance using immunotoxins

CA 2218166 C · Owner: Neville, David M. · Inventors: Thompson, Jerry T.; Ma, Shenglin; Thomas, Judith

CIPO record

Overview

Drawings and full text

Its claims, description and drawings are in the Canadian Patents Database.

Open the CIPO record

Abstract From the Canadian patent

Provided is a method of treating an immune system disorder not involving T-cell proliferation comprising administering to the animal an immunotoxin comprising a mutant diphtheria toxin moiety linked to an antibody moiety which routes by the anti-CD3 pathway or derivatives thereof under conditions such that the disorder is treated. Thus the present method can treat graft-versus-host disease. Also provided is a method of inhibiting a rejection response by inducing immune tolerance in a recipient to a foreign mammalian donor tissue or cells comprising the steps of: a) exposing the recipient to an immunotoxin so as to reduce the recipients' peripheral blood T-cell lymphocyte population by at …

Read the whole patent

Listed from its CIPO record in Patent Yard's archive of Canadian patents past their term. Its claims, description and drawings are in the CIPO record and on Google Patents, and the Claude kit works from them.

Why it's free to use

  • Filed April 12, 1996 and granted August 14, 2012. A Canadian patent filed from October 1, 1989 lasts 20 years from filing, so its term ended April 12, 2016.
  • A certificate of supplementary protection adds at most two years for a drug, so even that would have ended by April 12, 2018.
  • We check Canadian rights only. A patent in its family in another country could still be in force: check its family on Google Patents.
FiledApril 12, 1996
GrantedAugust 14, 2012
Term endedApril 12, 2016
Patent numberCA 2218166 C
Classification (IPC)A61K39/38 +2 more

Timeline

Timeline From CIPO dates

1997199920012003200520072009201120132015Application filedApril 12, 1996Patent grantedAug 14, 2012Term endedApril 12, 2016

Sources & verification

Everything on this page comes from the CIPO record linked above. Contains information licensed under the Open Government Licence – Canada.